Xuefeng He

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Kidney Transplantation

Top Venues

Bone marrow transplantation

This page only lists publications with an associated author ORCID identifier.

Publications

Zhiyu Zhang, Man Qiao, Xiebing Bao, Jing Lu, Jingren Zhang, Xueqing Dou, Xuefeng He, Xiao-Jin Wu, Chengcheng Fu, Xiao-Wen Tang, Miao Miao, Yue Han, Sheng-Li Xue, Huiying Qiu, Caixia Li, Ying Wang, Zhengming Jin, De-Pei Wu, Su-Ning Chen
Influence of the Omicron outbreak on allo-HSCT recipients in China: a single-center short-term observational cohort study. Bone marrow transplantation 59 (3) (2024)
Zhiyu Zhang, Man Qiao, Xiebing Bao, Jing Lu, Jingren Zhang, Xueqing Dou, Xuefeng He, Xiao-Jin Wu, Chengcheng Fu, Xiao-Wen Tang, Miao Miao, Yue Han, Sheng-Li Xue, Huiying Qiu, Caixia Li, Ying Wang, Zhengming Jin, De-Pei Wu, Su-Ning Chen
Influence of the Omicron outbreak on allo-HSCT recipients in China: a single-center short-term observational cohort study. Bone marrow transplantation 59 (3) (2024)
Zhiyu Zhang, Man Qiao, Xiebing Bao, Jing Lu, Jingren Zhang, Xueqing Dou, Xuefeng He, Xiao-Jin Wu, Chengcheng Fu, Xiao-Wen Tang, Miao Miao, Yue Han, Sheng-Li Xue, Huiying Qiu, Caixia Li, Ying Wang, Zhengming Jin, De-Pei Wu, Su-Ning Chen
Influence of the Omicron outbreak on allo-HSCT recipients in China: a single-center short-term observational cohort study. Bone marrow transplantation (2024)
Zhiyu Zhang, Man Qiao, Xiebing Bao, Jing Lu, Jingren Zhang, Xueqing Dou, Xuefeng He, Xiao-Jin Wu, Chengcheng Fu, Xiao-Wen Tang, Miao Miao, Yue Han, Sheng-Li Xue, Huiying Qiu, Caixia Li, Ying Wang, Zhengming Jin, De-Pei Wu, Su-Ning Chen
Influence of the Omicron outbreak on allo-HSCT recipients in China: a single-center short-term observational cohort study. Bone marrow transplantation 59 (3) (2024)
Fei Zhou, Tingting Pan, Xiaoli Li, Feng Du, Xiao Ma, Yanming Zhang, Depei Wu, Yue Han, Sheng-Li Xue, Miao Miao, Tao Tao, Xuefeng He, Suning Chen
Exploration of efficacy and safety of combined therapy of basiliximab with ruxolitinib for grade 3-4 steroid-refractory acute graft-versus-host disease: a registered clinical trial (NCT05021276). Bone marrow transplantation (2023)